Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Bombesin Receptor-BRS-3 agonist Compound A
BRS-3 agonist Compound A

Chemical Structure : BRS-3 agonist Compound A

CAS No.: 2489622-02-6

BRS-3 agonist Compound A (Compound-A)

Catalog No.: PC-61216Not For Human Use, Lab Use Only.

BRS-3 agonist Compound A (Compound-A) is a potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, respectively.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    BRS-3 agonist Compound A (Compound-A) is a potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, respectively.

    Physicochemical Properties

    M.Wt 428.532
    Formula C27H28N2O3
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    R-6-benzyl-N-tert-butyl-9-methoxy-7-oxo-6,7-dihydro-5H-dibenzo[c,e]azepine-5-carboxamide

    References

    1. Nio Y, et al. Endocrinology. 2017 May 1;158(5):1298-1313.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: